Multiple Model Dosage Design - PowerPoint PPT Presentation

About This Presentation
Title:

Multiple Model Dosage Design

Description:

Consider the effects of the pop outliers. Do a clinical simulation to validate each ... as made by Mallet. 11/26/09. USC LAPK. 7 'Multiple Model' Dosage Design ... – PowerPoint PPT presentation

Number of Views:276
Avg rating:3.0/5.0
Slides: 13
Provided by: rogerje5
Learn more at: http://www.lapk.org
Category:

less

Transcript and Presenter's Notes

Title: Multiple Model Dosage Design


1
Multiple ModelDosage Design
  • Roger Jelliffe, M.D.
  • USC Lab of Applied Pharmacokinetics

2
Conventional Design of Drug Dosage Regimens
  • Use Population Model
  • Select single target goal
  • Develop the dosage regimen to hit target
  • But will it? How precisely?
  • How to evaluate the expected precision?

3
(No Transcript)
4
Optimal Drug Dosage
  • Consider the effects of the pop outliers.
  • Do a clinical simulation to validate each
    regimen.
  • Standard Doses no feedback. Optimize them to
    hit desired targets.
  • Cancer Rx, Veterinary Rx.
  • Individualized Doses Optimize them also.
  • Targets are desired Conc, AUC, etc
  • AIDS, Transplants, Cancer, Antibiotics,
    Cardiovascular, etc.

5
What is the BEST Pop Model?
  • The correct structural PK/PD Model.
  • The collection of each subjects exactly known
    parameter values for that model.

6
An NPML Population Joint Density, as made by
Mallet
7
Multiple Model Dosage Design
  • Start with multiple models in pop model
  • Best starting tool NPAG joint density.
  • Compute regimen having least weighted squared
    error in target goal achievement.

8
(No Transcript)
9
Continuous IV Vanco. Predictions when regimen
based on means is given to all subjects
10
Vanco, continuous IV. Predictions from MM regimen
11
MM Optimal Dosage Regimens
  • Consider the quantitative effect of outliers.
  • A built-in simulated clinical trial each time.
  • Achieve target goals with max precision.
  • Get the best overall standard dose.
  • Best for Vet use, without feedback.
  • Best for Patient use, with or without feedback
    - cancer, AIDS, inf. Disease, CV disease.
  • Best optimally coordinated combination regimens
    in future.

12
Clinical Illustrations
  • Planning the initial regimen
  • Adjusting it based on TDM data
Write a Comment
User Comments (0)
About PowerShow.com